Archives: Agenda

For many biotech companies, clinical trial costs spiral beyond initial projections due to ineffective negotiation, unclear contracts, and overly optimistic budgeting. This practical, interactive workshop is designed to equip attendees with the tools and confidence to negotiate stronger contracts, build realistic budgets, and maintain financial discipline throughout the trial lifecycle. 

Through real-world examples and peer discussion, participants will learn how to secure value from CROs and vendors, avoid hidden costs, and ensure they only commit to spend that aligns with available funding, protecting both timelines and long-term viability. 

Key Learning Points

• How to build a robust, realistic clinical trial budget that reflects true operational costs
• Practical strategies to negotiate favourable contracts with CROs and vendors
• Identifying and managing hidden costs, scope creep, and change orders
• Techniques to ensure financial discipline – spending within available capital, not projections
• How to align finance, clinical operations, and procurement for stronger decision-making

Moderators will split the room into small groups, assign real-world tasks, guide discussions, and reconvene the audience to share key insights and approaches.

• Exploring the capability of Digital Display Labels (DDLs) and the benefits for Clinical Trial Supplies
• A demonstration of the functionality of DDLs; just in time labelling, lot & expiry update, multiple page count.
• Understanding the operational ability to securely & remotely update content & language.
• Integrating across IMP profiles, vials, bottles, blisters

Reserved for Biopharma

• Understanding the key factors that influence patients’ decisions to decline or withdraw from oncology clinical trials
• Exploring what sponsors, sites, and research teams can do to build greater trust, support, and engagement throughout the patient journey
• Case Study: Insights from Cancer CAREs International’s Next-Generation Trials project on reducing patient burden and creating more patient-centered trial experiences
• Sharing practical lessons learned and real-world examples of strategies that have improved patient participation, retention, and overall trial experience

Discover how artificial intelligence is transforming clinical research by streamlining processes from protocol design to regulatory submission. This session explores practical AI applications for overcoming recruitment challenges, ensuring ethical implementation, and shaping the future of oncology trials.

• Overcome Bottlenecks: Learn how AI breaks cycle inefficiencies in trial design and patient screening.
• Accelerate Recruitment: See how AI-driven models and molecular matching reduce screening time and failures.
• Implement Ethically: Understand frameworks for bias mitigation, data privacy, and regulatory compliance.
• Future Trends: Explore next-decade innovations like digital twins and foundation models.

Outcome: A candid, solution-focused discussion designed to help teams move faster and smarter.

• Addressing site burden during study start-up, recognising that sponsors often assume infrastructure and systems are already in place, when the reality can vary significantly between sites.
• Exploring how increasing protocol complexity is driving operational challenges and requiring sites to develop more creative and adaptable approaches to trial execution.
• Strengthening collaboration between sites, sponsors, and CROs to improve communication, efficiency, and study delivery.
• Creating an environment of trust where sites feel comfortable raising concerns around timelines, resources, and operational complexities without fear of losing future opportunities.
• Identifying practical strategies to reduce administrative burden while maintaining quality, compliance, and patient-focused outcomes.